Substance / Medication

Halothane

Overview

Active Ingredient
halothane
RxNorm CUI
5095

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Meta-analysis of the effect of the halothane gene on 6 variables of pig meat quality and on carcass leanness.
Salmi B, Trefan L, Bloom-Hansen J et al. · J Anim Sci · 2010
PMID: 20348370Meta-Analysis
The bispectral index during recovery from halothane and sevoflurane anaesthesia in horses.
Belda Eliseo, Beldao Eliseo, Blissitt Karen J et al. · Vet Anaesth Analg · 2010
PMID: 20017816RCT
The post-tetanic count during vecuronium-induced neuromuscular blockade in halothane-anaesthetized dogs.
Sarrafzadeh-Rezaei Farshid, Eddie Clutton R · Vet Anaesth Analg · 2009
PMID: 19397776RCT
EEG entropy values during isoflurane, sevoflurane and halothane anesthesia with and without nitrous oxide.
Prabhakar Hemanshu, Ali Zulfiqar, Bithal Parmod K et al. · J Neurosurg Anesthesiol · 2009
PMID: 19295388RCT
Thiopental and halothane dose-sparing effects of magnesium sulphate in dogs.
Anagnostou Tilemahos L, Savvas Ioannis, Kazakos George M et al. · Vet Anaesth Analg · 2008
PMID: 17850224RCT
The performance of Bispectral Index in children during equi-MAC halothane vs. sevoflurane anaesthesia.
Taivainen T, Klockars J, Hiller A et al. · Eur J Anaesthesiol · 2008
PMID: 18652710RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Halothane (substance)
SNOMED CT
387351001
UMLS CUI
C0018549
RxNorm CUI
5095

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.